Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity

Biochemical Pharmacology - Tập 73 - Trang 1499-1510 - 2007
Man Jiang1, Qingqing Wei1, Navjotsin Pabla1, Guie Dong1, Cong-Yi Wang2, Tianxin Yang3, Sylvia B. Smith1, Zheng Dong1
1Department of Cellular Biology and Anatomy, Medical College of Georgia and Veterans Affairs Medical Center, 1459 Laney Walker Blvd., Augusta, GA 30912, United States
2Center for Genomic Medicine, Medical College of Georgia and Veterans Affairs Medical Center, 1459 Laney Walker Blvd., Augusta, GA 30912, United States
3Department of Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, UT 84148, United States

Tài liệu tham khảo

Fuertesa, 2003, Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways, Curr Med Chem, 10, 257, 10.2174/0929867033368484 Siddik, 2003, Cisplatin: mode of cytotoxic action and molecular basis of resistance, Oncogene, 22, 7265, 10.1038/sj.onc.1206933 Arany, 2003, Cisplatin nephrotoxicity, Semin Nephrol, 23, 460, 10.1016/S0270-9295(03)00089-5 Taguchi, 2005, Cisplatin-associated nephrotoxicity and pathological events, Contrib Nephrol, 148, 107, 10.1159/000086055 Lieberthal, 1996, Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis, Am J Physiol, 270, F700 Baliga, 1998, In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity, Kidney Int, 53, 394, 10.1046/j.1523-1755.1998.00767.x Kaushal, 2001, Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells, Kidney Int, 60, 1726, 10.1046/j.1523-1755.2001.00026.x Liu, 2003, Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis, Kidney Int, 63, 1687, 10.1046/j.1523-1755.2003.00908.x Megyesi, 1998, Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure, J Clin Invest, 101, 777, 10.1172/JCI1497 Nowak, 2002, Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells, J Biol Chem, 277, 43377, 10.1074/jbc.M206373200 Park, 2002, Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways, J Am Soc Nephrol, 13, 858, 10.1681/ASN.V134858 Ramesh, 2002, TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity, J Clin Invest, 110, 835, 10.1172/JCI200215606 Tsuruya, 2003, Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death, Kidney Int, 63, 72, 10.1046/j.1523-1755.2003.00709.x Shiraishi, 2000, Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis, Am J Physiol Renal Physiol, 278, F726, 10.1152/ajprenal.2000.278.5.F726 Sheikh-Hamad, 2004, Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney, Arch Toxicol, 78, 147, 10.1007/s00204-003-0521-4 Li, 2004, PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G, Am J Physiol Renal Physiol, 287, F990, 10.1152/ajprenal.00206.2004 Arany, 2004, Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells, Am J Physiol Renal Physiol, 287, F543, 10.1152/ajprenal.00112.2004 Yu, 2005, Identification of the functional domain of p21WAF1/CIP1 that protects from cisplatin cytotoxicity, Am J Physiol Renal Physiol, 289, F514, 10.1152/ajprenal.00101.2005 Cummings, 2002, Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways, J Pharmacol Exp Ther, 302, 8, 10.1124/jpet.302.1.8 Jiang, 2004, Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity, Am J Physiol Renal Physiol, 287, F1140, 10.1152/ajprenal.00262.2004 Seth, 2005, p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury, J Biol Chem, 280, 31230, 10.1074/jbc.M503305200 Jiang, 2006, Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis, Oncogene, 25, 4056, 10.1038/sj.onc.1209440 Baliga, 1999, Oxidant mechanisms in toxic acute renal failure, Drug Metab Rev, 31, 971, 10.1081/DMR-100101947 Nath, 2000, Reactive oxygen species and acute renal failure, Am J Med, 109, 665, 10.1016/S0002-9343(00)00612-4 Martindale, 2002, Cellular response to oxidative stress: signaling for suicide and survival, J Cell Physiol, 192, 1, 10.1002/jcp.10119 Baek, 2003, Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells, J Lab Clin Med, 142, 178, 10.1016/S0022-2143(03)00111-2 Matsushima, 1998, The role of oxygen free radicals in cisplatin-induced acute renal failure in rats, J Lab Clin Med, 131, 518, 10.1016/S0022-2143(98)90060-9 Ramesh, 2005, p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice, Am J Physiol Renal Physiol, 289, F166, 10.1152/ajprenal.00401.2004 Satoh, 2003, A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo, J Pharmacol Exp Ther, 305, 1183, 10.1124/jpet.102.047522 Sueishi, 2002, Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats, Eur J Pharmacol, 451, 203, 10.1016/S0014-2999(02)02251-3 Tsuruya, 2003, Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways, Am J Physiol Renal Physiol, 285, F208, 10.1152/ajprenal.00311.2002 Halliwell, 1988, Methods for the measurement of hydroxyl radicals in biomedical systems: deoxyribose degradation and aromatic hydroxylation, Methods Biochem Anal, 33, 59, 10.1002/9780470110546.ch2 Wang, 2004, Minocycline up-regulates Bcl-2 and protects against cell death in the mitochondria, J Biol Chem, 279, 19948, 10.1074/jbc.M313629200 Dong, 2004, Hypoxia selection of death-resistant cells: a role for Bcl-XL, J Biol Chem, 279, 9215, 10.1074/jbc.M312225200 Gottlieb, 2002, Analyzing mitochondrial changes during apoptosis, Methods, 26, 341, 10.1016/S1046-2023(02)00040-3 Dong, 2003, Apoptosis-resistance of hypoxic cells: multiple factors involved and a role for IAP-2, Am J Pathol, 163, 663, 10.1016/S0002-9440(10)63693-0 Wei, 2005, Differential gender differences in ischemic and nephrotoxic acute renal failure, Am J Nephrol, 25, 491, 10.1159/000088171 Wei, 2006, Bid deficiency ameliorates ischemic renal failure and delays animal death in C57BL/6 mice, Am J Physiol Renal Physiol, 290, F35, 10.1152/ajprenal.00184.2005 Ramesh, 2003, TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure, Am J Physiol Renal Physiol, 285, F610, 10.1152/ajprenal.00101.2003 Bode, 2004, Post-translational modification of p53 in tumorigenesis, Nat Rev Cancer, 4, 793, 10.1038/nrc1455 Vousden, 2002, Live or let die: the cell's response to p53, Nat Rev Cancer, 2, 594, 10.1038/nrc864 Norbury, 2004, DNA damage-induced apoptosis, Oncogene, 23, 2797, 10.1038/sj.onc.1207532 Shiloh, 2003, ATM and related protein kinases: safeguarding genome integrity, Nat Rev Cancer, 3, 155, 10.1038/nrc1011 Wang, 2006, Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53, Am J Physiol Renal Physiol, 291, F1300, 10.1152/ajprenal.00509.2005 Kim, 2005, Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells, J Appl Toxicol, 25, 374, 10.1002/jat.1081